Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 077668

Expand all

CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE)
EQ 10MG BASE
Marketing Status: Discontinued

Active Ingredient: CITALOPRAM HYDROBROMIDE
Proprietary Name: CITALOPRAM HYDROBROMIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A077668
Product Number: 001
Approval Date: Feb 28, 2007
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE)
EQ 20MG BASE
Marketing Status: Discontinued

Active Ingredient: CITALOPRAM HYDROBROMIDE
Proprietary Name: CITALOPRAM HYDROBROMIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 20MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A077668
Product Number: 002
Approval Date: Feb 28, 2007
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE)
EQ 40MG BASE
Marketing Status: Discontinued

Active Ingredient: CITALOPRAM HYDROBROMIDE
Proprietary Name: CITALOPRAM HYDROBROMIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 40MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A077668
Product Number: 003
Approval Date: Feb 28, 2007
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information